29 Apr 2022
IQ-EQ wins ‘Fund Administrator of the Year’ in 2022 Private Equity Awards
IQ-EQ has won ‘Fund Administrator of the Year’ in the industry-renowned Private Equity Awards.
27 Apr 2022
IQ-EQ appoints new Group Chief Risk Officer
Sally Alayarian is named as IQ-EQ’s new Group Chief Risk Officer.
20 Apr 2022
IQ-EQ Group completes U.S. rebrand
IQ-EQ is pleased to announce that our U.S. based Group companies – Blue River Partners LLC, Constellation Advisers LLC, Concord Trust Company and Greyline Partners LLC – have today rebranded as IQ-EQ, completing a major milestone in our Group’s acquisitive U.S. strategy.
19 Apr 2022
IQ-EQ shortlisted for three awards in the Drawdown Awards 2022
IQ-EQ is delighted to announce that we have been shortlisted for three categories in the 2022 Drawdown Awards.
13 Apr 2022
IQ-EQ appoints new Chief Commercial Officer for Asia
David Kim has been named as IQ-EQ’s new Chief Commercial Officer for Asia as the leading global investor services group expands its client base in the region.
13 Apr 2022
IQ-EQ names Chief Commercial Officer for Luxembourg
IQ-EQ is pleased to name Bram Eijsbouts as our new Chief Commercial Officer (CCO) for Luxembourg. This appointment comes as the group seeks to strengthen its global commercial leadership team and advance its organic growth agenda.
01 Apr 2022
IQ-EQ reinforces Client Services team in Asia
Leading investor services group IQ-EQ is pleased to announce two senior additions to its Client Services team in Asia. Andréia Prates and Rachael Leung both join the business as client service directors.
29 Mar 2022
IQ-EQ appoints new Group Head of Compliance
Tasnoova Zaki, an experienced regulation specialist, has been named as IQ-EQ’s new Group Head of Compliance.
09 Mar 2022
IQ-EQ welcomes EG Capital to Launchpad programme
IQ-EQ is delighted to be assisting impact investment firm EG Capital with the launch of its maiden fund. EG Capital is on board as part of our unique IQ-EQ Launchpad initiative, delivering tailored support to female first-time fund managers.